Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print June 10, 2008
DOI: 10.2337/db07-1541

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-1541v1
57/9/2371    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Song, W.-J.
Right arrow Articles by Hussain, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Song, W.-J.
Right arrow Articles by Hussain, M. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Exendin-4 stimulation of cyclin A2 in β-cell proliferation

Woo-Jin Song, Weston E. Schreiber, Enhong Zhong, Fei-Fei Liu, Benjamin D. Kornfeld, Fredric E. Wondisford, and Mehboob A. Hussain

Metabolism Division, Departments of Pediatrics and Medicine, Johns Hopkins University

Objective.: β-cell proliferation is an important mechanism underlying β-cell mass adaptation to metabolic demands. We have examined effects - in particular those mediated through intracellular cyclic AMP signaling - of the incretin hormone analogue exendin-4 on cell cycle regulation in β-cells.

Research Design and Methods.: Changes in islet protein levels of cyclins and of two critical cell cycle regulators cyclin kinase inhibitor p27 and S-phase kinase-associated protein 2 (Skp2) were assessed in mice treated with exendin-4 and in a mouse model with specific upregulation of nuclear cAMP signaling exhibiting increased β-cell proliferation (CBP-S436A mouse). Because cyclin A2 was stimulated by cyclic AMP, we assessed the role of cylcin A2 in cell cycle progression in Min6 and isolated islet β-cells.

Results.: Mice treated with exendin-4 showed increased β-cell proliferation, elevated islet protein levels of cyclin A2 with unchanged D-type cyclins, and elevated PDX-1, Skp2 and reduced p27 levels. Exendin-4 stimulated cyclin A2 promoter activity via the cyclic AMP (cAMP) - cyclic AMP response element binding protein pathway. CBP-S436A islets exhibited elevated cyclin A2, reduced p27, and no changes in D-type cyclins, PDX-1, or Skp2. In cultured islets, exendin-4 increased cyclin A2, Skp2 and reduced p27. Cyclin A2 overexpression in primary islets increased proliferation and reduced p27. In Min6 cells, cyclin A2 knockdown prevented exendin-4 stimulated proliferation. PDX-1 knockdown reduced exendin-4 stimulated cAMP synthesis and cyclin A2 transcription.

Conclusions.: Cyclin A2 is required for β-cell proliferation, exendin-4 stimulates cyclin A2 expression via the cAMP pathway, and exendin-4 stimulation of cAMP requires PDX-1.


Correspondence: mhussai4{at}jhmi.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.